Loading insider details...
Latest Form 4 (Jun 12, 2026): Exercise/Conversion of 34,090 RCUS shares, $87.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Arcus Biosciences, Inc. (RCUS) | Exercise/Conversion | 34,090 | $87.7K |
| Jan 27, 2026 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 24,000 | n/a |
| Dec 18, 2025 | Arcus Biosciences, Inc. (RCUS) | Sale | 7,658 | $167.6K |
| Jan 27, 2025 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 37,000 | n/a |
| Dec 18, 2024 | Arcus Biosciences, Inc. (RCUS) | Tax Withholding | 11,339 | $182.3K |
| Jun 18, 2024 | Arcus Biosciences, Inc. (RCUS) | Tax Withholding | 4,182 | $71.0K |
| Jan 26, 2024 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 26,700 | n/a |
| Dec 20, 2023 | Arcus Biosciences, Inc. (RCUS) | Disposition to Issuer | 3,991 | $70.8K |
| Jun 17, 2023 | Arcus Biosciences, Inc. (RCUS) | Disposition to Issuer | 2,892 | $56.0K |
| Jan 25, 2023 | Arcus Biosciences, Inc. (RCUS) | Grant/Award | 34,000 | n/a |